At Aviiana, our mission has always been clear: to transform how women experience menopause and midlife health. We believe women deserve better — more support, more science, and more solutions. That’s why we’re proud to announce our partnership with Myopharm, an Australian biotechnology company dedicated to developing life-changing products for chronic conditions and women’s health.
Why Myopharm?
Founded by Karinza Phoenix in 2020, Myopharm brings together a world-class team of scientists, clinicians, and innovators with one mission: to change the way we prevent and manage metabolic health conditions. While Myopharm’s roots are in addressing diabetes and related inflammatory disorders, the team has increasingly turned their focus toward women’s health — including PCOS, gestational diabetes, and peri-menopause.
This shared commitment to improving women’s lives makes Myopharm and Aviiana natural allies. Together, we’re not just imagining a better future — we’re building it.
Behind Myopharm’s innovations is a passionate team committed to making women’s health a priority:
Karinza Phoenix, Founding CEO & Managing Director
With a career spanning veterinary science, capital markets, and biotechnology, Karinza founded Myopharm to commercialise products that change lives. She has a clear vision: to make a difference to millions of people living with metabolic disorders and to extend that impact into women’s health.
Tamara Miller, Head of Clinical Development
With 22 years in pharmaceuticals and biotech across the US, UK, and Australia, Tamara leads Myopharm’s clinical development. She is particularly excited about the Aviiana partnership:
“Our products have the potential to help women navigating peri- and menopause. Backed by science, they provide alternatives that genuinely support health at this critical stage.”
Dr George Tachas, Chief Scientific Officer
A scientist with over 26 years of experience, more than 110 patents, and deep expertise in autoimmune and endocrine disorders, George is driving innovation behind Myopharm’s pipeline. His passion is translating science into real-world solutions, like the OMNI range, that make a tangible difference.
Advait Padhye, Research Associate
Bringing fresh energy and focus, Advait is passionate about the OMNI product line. He believes in creating clinically validated lifestyle supplements that cut through the noise of ineffective “quick fixes” in the market — giving women access to products that truly work.
Together, this team combines experience, innovation, and empathy to address some of the biggest challenges in women’s health today.
Science Meets Support
Myopharm’s OMNI range bridges science with everyday life:
|
|
 |
|
OMNI-e® — a sugar-free electrolyte solution designed for hydration without impacting blood sugar, enriched with calcium, magnesium, and natural Australian ingredients.
|
OMNI-D® — a patented pre-meal protein and fibre drink, clinically shown to reduce post-meal blood sugar spikes by 36%. By smoothing out energy peaks and troughs, OMNI-D® helps women feel fuller for longer while supporting long-term metabolic and cognitive health.
|
These products are the result of over a decade of Australian-led research in partnership with leading institutions like the University of Adelaide and the Baker Heart & Diabetes Institute.
Why This Matters for Women in Midlife
Perimenopause and menopause can bring profound shifts in metabolism, weight, and energy — yet women often lack effective, science-backed tools to manage these changes. Myopharm’s innovations, combined with Aviiana’s education and community, offer women not just products, but a movement of support and empowerment.
The Beginning of Something Bigger
This partnership is more than business. It’s about women supporting women. It’s about science meeting lived experience. And it’s about building a future where menopause and midlife health are not hidden, ignored, or underserved — but celebrated and supported with care.
Together, Aviiana and Myopharm are creating solutions that not only work, but empower.
Because midlife is not the end of the story. It’s the beginning of a new one.
